PharmacoEconomics via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'PharmacoEconomics' source. Thu, 09 Feb 2012 10:13:03 +0100 Osteoporotic Fractures: A Systematic Review of US Healthcare Costs and Resource Utilization http://www.medworm.com/index.php?rid=5615748&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000002%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5615748 Sat, 21 Jan 2012 14:53:51 +0100 5615748 Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery: A NICE Single Technology Appraisal http://www.medworm.com/index.php?rid=5615747&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000002%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5615747 Sat, 21 Jan 2012 14:53:51 +0100 5615747 Real Economics Needs to Reflect Real Decisions: A Response to Johnson http://www.medworm.com/index.php?rid=5615746&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000002%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5615746 Sat, 21 Jan 2012 14:53:51 +0100 5615746 Why Not Real Economics? http://www.medworm.com/index.php?rid=5615745&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000002%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5615745 Sat, 21 Jan 2012 14:53:51 +0100 5615745 Incorporating Calibrated Model Parameters into Sensitivity Analyses: Deterministic and Probabilistic Approaches http://www.medworm.com/index.php?rid=5615744&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000002%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5615744 Sat, 21 Jan 2012 14:53:51 +0100 5615744 Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer http://www.medworm.com/index.php?rid=5615743&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000002%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5615743 Sat, 21 Jan 2012 14:53:51 +0100 5615743 Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payers Perspective http://www.medworm.com/index.php?rid=5615742&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000002%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5615742 Sat, 21 Jan 2012 14:53:51 +0100 5615742 Erratum http://www.medworm.com/index.php?rid=5510833&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000001%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5510833 Sat, 17 Dec 2011 03:21:49 +0100 5510833 A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis http://www.medworm.com/index.php?rid=5510832&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000001%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5510832 Sat, 17 Dec 2011 03:21:49 +0100 5510832 Does the EQ-5D Reflect Lost Earnings? http://www.medworm.com/index.php?rid=5510831&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000001%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5510831 Sat, 17 Dec 2011 03:21:49 +0100 5510831 Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal http://www.medworm.com/index.php?rid=5510830&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000001%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5510830 Sat, 17 Dec 2011 03:21:49 +0100 5510830 Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review http://www.medworm.com/index.php?rid=5510829&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000001%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5510829 Sat, 17 Dec 2011 03:21:49 +0100 5510829 Economic and Humanistic Burden of External Genital Warts http://www.medworm.com/index.php?rid=5510828&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2012%2F00000030%2F00000001%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5510828 Wed, 14 Dec 2011 02:06:17 +0100 5510828 Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective http://www.medworm.com/index.php?rid=5463742&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000012%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5463742 Fri, 02 Dec 2011 03:59:55 +0100 5463742 Cost-Effectiveness Analysis of Prophylactic Lamivudine Use in Preventing Vertical Transmission of Hepatitis B Virus Infection http://www.medworm.com/index.php?rid=5463741&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000012%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5463741 Fri, 02 Dec 2011 03:59:55 +0100 5463741 Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal http://www.medworm.com/index.php?rid=5463740&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000012%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5463740 Fri, 02 Dec 2011 03:59:55 +0100 5463740 Modelling the Cost Effectiveness of Treatments for Parkinsons Disease: A Methodological Review http://www.medworm.com/index.php?rid=5463739&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000012%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5463739 Fri, 02 Dec 2011 03:59:55 +0100 5463739 QALYs and Carers http://www.medworm.com/index.php?rid=5463738&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000012%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5463738 Fri, 02 Dec 2011 03:59:55 +0100 5463738 Erratum http://www.medworm.com/index.php?rid=5463737&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000012%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5463737 Fri, 02 Dec 2011 03:59:55 +0100 5463737 Acknowledgement http://www.medworm.com/index.php?rid=5463736&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000012%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5463736 Wed, 30 Nov 2011 02:05:58 +0100 5463736 Rotavirus Vaccine RIX4414 (Rotarix): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries http://www.medworm.com/index.php?rid=5320225&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000011%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5320225 Sun, 16 Oct 2011 05:39:48 +0100 5320225 Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma http://www.medworm.com/index.php?rid=5320224&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000011%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5320224 Sun, 16 Oct 2011 05:39:48 +0100 5320224 Willingness to Pay for Adverse Drug Event Regulatory Actions http://www.medworm.com/index.php?rid=5320223&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000011%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5320223 Sun, 16 Oct 2011 05:39:48 +0100 5320223 Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women: A NICE Single Technology Appraisal http://www.medworm.com/index.php?rid=5320222&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000011%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5320222 Sun, 16 Oct 2011 05:39:48 +0100 5320222 Sample Size Determination for Cost-Effectiveness Trials http://www.medworm.com/index.php?rid=5320221&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000011%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5320221 Sun, 16 Oct 2011 05:39:48 +0100 5320221 Utility Estimation in Chronic Obstructive Pulmonary Disease: A Preference for Change? http://www.medworm.com/index.php?rid=5320220&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000011%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5320220 Sun, 16 Oct 2011 05:39:48 +0100 5320220 The Importance of the Comparator in Economic Evaluations: Working on the Efficiency Frontier http://www.medworm.com/index.php?rid=5320219&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000011%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5320219 Fri, 14 Oct 2011 02:06:44 +0100 5320219 Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium http://www.medworm.com/index.php?rid=5216687&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000010%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5216687 Wed, 14 Sep 2011 08:06:43 +0100 5216687 Critical Assessment of Belgian Reimbursement Dossiers of Orphan Drugs http://www.medworm.com/index.php?rid=5216686&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000010%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5216686 Wed, 14 Sep 2011 08:06:43 +0100 5216686 Does the Market Share of Generic Medicines Influence the Price Level?: A European Analysis http://www.medworm.com/index.php?rid=5216685&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000010%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5216685 Wed, 14 Sep 2011 08:06:43 +0100 5216685 Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer: A Systematic Review of the Literature http://www.medworm.com/index.php?rid=5216684&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000010%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5216684 Wed, 14 Sep 2011 08:06:43 +0100 5216684 A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease: Implications for Policy http://www.medworm.com/index.php?rid=5216683&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000010%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5216683 Wed, 14 Sep 2011 08:06:43 +0100 5216683 Cautions Regarding the Fitting and Interpretation of Survival Curves: Examples from NICE Single Technology Appraisals of Drugs for Cancer http://www.medworm.com/index.php?rid=5216682&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000010%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5216682 Wed, 14 Sep 2011 08:06:43 +0100 5216682 Addressing the Challenge for Well Informed and Consistent Reimbursement Decisions: The Case for Reference Models http://www.medworm.com/index.php?rid=5216681&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000010%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5216681 Tue, 13 Sep 2011 02:06:07 +0100 5216681 Cinacalcet: A Pharmacoeconomic Review of its Use in Secondary Hyperparathyroidism in End-Stage Renal Disease http://www.medworm.com/index.php?rid=5136834&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000009%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5136834 Wed, 17 Aug 2011 14:55:33 +0100 5136834 Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand http://www.medworm.com/index.php?rid=5136833&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000009%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5136833 Wed, 17 Aug 2011 14:55:33 +0100 5136833 To Fund or Not to Fund: Development of a Decision-Making Framework for the Coverage of New Health Technologies http://www.medworm.com/index.php?rid=5136832&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000009%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5136832 Wed, 17 Aug 2011 14:55:33 +0100 5136832 Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure: A Systematic Review http://www.medworm.com/index.php?rid=5136831&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000009%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5136831 Wed, 17 Aug 2011 14:55:33 +0100 5136831 Cost Benefit and Cost Effectiveness of Antifungal Prophylaxis in Immunocompromised Patients Treated for Haematological Malignancies: Reviewing the Available Evidence http://www.medworm.com/index.php?rid=5136830&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000009%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5136830 Wed, 17 Aug 2011 14:55:33 +0100 5136830 Value-Based Pricing: Incentive for Innovation or Zero Net Benefit? http://www.medworm.com/index.php?rid=5136829&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000009%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5136829 Tue, 16 Aug 2011 02:06:01 +0100 5136829 Estimating the Relationship between Preference-Based Generic Utility Instruments and Disease-Specific Quality-of-Life Measures in Severe Chronic Constipation: Challenges in Practice http://www.medworm.com/index.php?rid=5016097&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000008%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5016097 Tue, 12 Jul 2011 18:55:27 +0100 5016097 Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients http://www.medworm.com/index.php?rid=5016096&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000008%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5016096 Tue, 12 Jul 2011 18:55:27 +0100 5016096 Cost Estimation of Cardiovascular Disease Events in the US http://www.medworm.com/index.php?rid=5016095&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000008%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5016095 Tue, 12 Jul 2011 18:55:27 +0100 5016095 US FDA Modernization Act, Section 114: Uses, Opportunities and Implications for Comparative Effectiveness Research http://www.medworm.com/index.php?rid=5016094&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000008%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5016094 Tue, 12 Jul 2011 18:55:27 +0100 5016094 Using QALYs in Cancer: A Review of the Methodological Limitations http://www.medworm.com/index.php?rid=5016093&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000008%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5016093 Tue, 12 Jul 2011 18:55:27 +0100 5016093 Cost-of-Illness Studies: A Guide to Critical Evaluation http://www.medworm.com/index.php?rid=5016092&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000008%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5016092 Tue, 12 Jul 2011 18:55:27 +0100 5016092 Challenges in Health State Valuation in Paediatric Economic Evaluation: Are QALYs Contraindicated? http://www.medworm.com/index.php?rid=5016091&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000008%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5016091 Tue, 12 Jul 2011 18:55:27 +0100 5016091 The Case for Less, Not More, US FDA Regulation http://www.medworm.com/index.php?rid=5016090&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000008%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=5016090 Tue, 12 Jul 2011 02:06:08 +0100 5016090 Medication Costs to Private Insurers of Diversion of Medications for Attention-Deficit Hyperactivity Disorder http://www.medworm.com/index.php?rid=4943459&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000007%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4943459 Sun, 19 Jun 2011 04:56:57 +0100 4943459 Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders http://www.medworm.com/index.php?rid=4943458&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000007%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4943458 Sun, 19 Jun 2011 04:56:57 +0100 4943458 Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV: A Systematic Review for Low- and Middle-Income Countries http://www.medworm.com/index.php?rid=4943457&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000007%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4943457 Sun, 19 Jun 2011 04:56:57 +0100 4943457 Presenting Evidence and Summary Measures to Best Inform Societal Decisions When Comparing Multiple Strategies http://www.medworm.com/index.php?rid=4943456&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000007%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4943456 Sun, 19 Jun 2011 04:56:57 +0100 4943456 Prioritizing Comparative Effectiveness Research: Are Drug and Implementation Trials Equally Worth Funding? http://www.medworm.com/index.php?rid=4943455&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000007%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4943455 Sun, 19 Jun 2011 04:56:57 +0100 4943455 Reflections on the Changing Face of German Pharmaceutical Policy: How Far is Germany from Value-Based Pricing? http://www.medworm.com/index.php?rid=4943454&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000007%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4943454 Sun, 19 Jun 2011 02:06:46 +0100 4943454 PAID 1.0 in Practice: A Brief Clarification Regarding its Possibilities and Limitations http://www.medworm.com/index.php?rid=4838247&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000006%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4838247 Thu, 19 May 2011 18:17:30 +0100 4838247 Intravenous Esomeprazole: A Pharmacoeconomic Profile of its Use in the Prevention of Recurrent Peptic Ulcer Bleeding http://www.medworm.com/index.php?rid=4838246&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000006%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4838246 Thu, 19 May 2011 18:17:30 +0100 4838246 A Value Set for the EQ-5D Based on Experienced Health States: Development and Testing for the German Population http://www.medworm.com/index.php?rid=4838245&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000006%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4838245 Thu, 19 May 2011 18:17:30 +0100 4838245 The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia http://www.medworm.com/index.php?rid=4838244&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000006%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4838244 Thu, 19 May 2011 18:17:30 +0100 4838244 A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data http://www.medworm.com/index.php?rid=4838243&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000006%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4838243 Thu, 19 May 2011 18:17:30 +0100 4838243 Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different http://www.medworm.com/index.php?rid=4838242&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000006%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4838242 Thu, 19 May 2011 18:17:30 +0100 4838242 Pharmacoeconomic Considerations in Treating Iron Overload in Patients with -Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US: A Literature Review http://www.medworm.com/index.php?rid=4838241&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000006%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4838241 Thu, 19 May 2011 18:17:30 +0100 4838241 The Appropriate Elicitation of Expert Opinion in Economic Models: Making Expert Data Fit for Purpose http://www.medworm.com/index.php?rid=4838240&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000006%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4838240 Thu, 19 May 2011 02:06:08 +0100 4838240 Rotavirus Vaccine RIX4414 (Rotarix): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developed Countries http://www.medworm.com/index.php?rid=4740675&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00010 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740675 Sat, 23 Apr 2011 02:37:27 +0100 4740675 The Authors Reply http://www.medworm.com/index.php?rid=4740674&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00009 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740674 Sat, 23 Apr 2011 02:37:27 +0100 4740674 Is There a Role for Pharmacoeconomics in Developing Countries? http://www.medworm.com/index.php?rid=4740673&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740673 Sat, 23 Apr 2011 02:37:27 +0100 4740673 Updated Cost-Effectiveness Analysis of Trastuzumab for Early Breast Cancer: A UK Perspective Considering Duration of Benefit, Long-Term Toxicity and Pattern of Recurrence http://www.medworm.com/index.php?rid=4740671&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740671 Sat, 23 Apr 2011 02:37:27 +0100 4740671 Cost Effectiveness of BudesonideFormoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives http://www.medworm.com/index.php?rid=4740670&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740670 Sat, 23 Apr 2011 02:37:27 +0100 4740670 Cost Effectiveness of Treatments for Inflammatory Bowel Disease http://www.medworm.com/index.php?rid=4740669&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740669 Sat, 23 Apr 2011 02:37:27 +0100 4740669 Modelling the Epidemiology of Infectious Diseases for Decision Analysis: A Primer http://www.medworm.com/index.php?rid=4740668&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740668 Sat, 23 Apr 2011 02:37:27 +0100 4740668 Health Economic and Infectious Disease Modelling: A Guide to Merging Streams http://www.medworm.com/index.php?rid=4740667&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740667 Sat, 23 Apr 2011 02:37:27 +0100 4740667 Adjuvant Trastuzumab for Breast Cancer: Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA Trial http://www.medworm.com/index.php?rid=4740666&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000005%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4740666 Fri, 22 Apr 2011 02:06:43 +0100 4740666 Bivalirudin: A Pharmacoeconomic Profile of its Use in Patients with Acute Coronary Syndromes http://www.medworm.com/index.php?rid=4589248&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000004%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4589248 Tue, 15 Mar 2011 20:40:45 +0100 4589248 Economic Burden of Renal Cell Carcinoma in the US: Part II An Updated Analysis http://www.medworm.com/index.php?rid=4589247&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000004%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4589247 Tue, 15 Mar 2011 20:40:45 +0100 4589247 Economic Burden of Renal Cell Carcinoma: Part I An Updated Review http://www.medworm.com/index.php?rid=4589246&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000004%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4589246 Tue, 15 Mar 2011 20:40:45 +0100 4589246 Sensitivity Analysis in Cost-Effectiveness Studies: From Guidelines to Practice http://www.medworm.com/index.php?rid=4589245&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000004%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4589245 Tue, 15 Mar 2011 20:40:45 +0100 4589245 Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay http://www.medworm.com/index.php?rid=4589244&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000004%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4589244 Tue, 15 Mar 2011 20:40:45 +0100 4589244 The Role of Bortezomib, Thalidomide and Lenalidomide in the Management of Multiple Myeloma: An Overview of Clinical and Economic Information http://www.medworm.com/index.php?rid=4589243&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000004%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4589243 Tue, 15 Mar 2011 02:06:35 +0100 4589243 Posaconazole: A Pharmacoeconomic Review of its Use in the Prophylaxis of Invasive Fungal Disease in Immunocompromised Hosts http://www.medworm.com/index.php?rid=4488094&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000003%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4488094 Thu, 17 Feb 2011 23:46:25 +0100 4488094 Comparing Methods of Data Synthesis: Re-Estimating Parameters of an Existing Probabilistic Cost-Effectiveness Model http://www.medworm.com/index.php?rid=4488093&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000003%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4488093 Thu, 17 Feb 2011 23:46:25 +0100 4488093 Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors http://www.medworm.com/index.php?rid=4488092&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000003%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4488092 Thu, 17 Feb 2011 23:46:25 +0100 4488092 Advances in Cancer Therapeutics and Patient Access to New Drugs http://www.medworm.com/index.php?rid=4488091&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000003%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4488091 Thu, 17 Feb 2011 23:46:25 +0100 4488091 Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children: A Review http://www.medworm.com/index.php?rid=4488090&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000003%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4488090 Thu, 17 Feb 2011 23:46:25 +0100 4488090 Sample Size and Power for Cost-Effectiveness Analysis (Part 1) http://www.medworm.com/index.php?rid=4488089&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000003%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4488089 Thu, 17 Feb 2011 23:46:25 +0100 4488089 Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations http://www.medworm.com/index.php?rid=4488088&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000003%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4488088 Thu, 17 Feb 2011 23:46:25 +0100 4488088 Including Indirect Medical Care Costs from Survivor Years of Life in Economic Evaluations http://www.medworm.com/index.php?rid=4488087&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000003%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4488087 Thu, 17 Feb 2011 02:06:37 +0100 4488087 Erratum http://www.medworm.com/index.php?rid=4381464&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000002%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4381464 Fri, 21 Jan 2011 22:12:03 +0100 4381464 Impact of Treatment Success on Health Service Use and Cost in Depression: Longitudinal Database Analysis http://www.medworm.com/index.php?rid=4381463&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000002%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4381463 Fri, 21 Jan 2011 22:12:03 +0100 4381463 A Systematic Review to Assess the Policy-Making Relevance of Dementia Cost-of-Illness Studies in the US and Canada http://www.medworm.com/index.php?rid=4381462&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000002%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4381462 Fri, 21 Jan 2011 22:12:03 +0100 4381462 Febuxostat for the Management of Hyperuricaemia in Patients with Gout: A NICE Single Technology Appraisal http://www.medworm.com/index.php?rid=4381461&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000002%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4381461 Fri, 21 Jan 2011 22:12:03 +0100 4381461 Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration http://www.medworm.com/index.php?rid=4381460&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000002%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4381460 Fri, 21 Jan 2011 22:12:03 +0100 4381460 A Model to Transfer Trial-Based Pharmacoeconomic Analyses to Clinical Practice http://www.medworm.com/index.php?rid=4381459&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000002%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4381459 Fri, 21 Jan 2011 22:12:03 +0100 4381459 Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest http://www.medworm.com/index.php?rid=4381458&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000002%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4381458 Fri, 21 Jan 2011 02:06:34 +0100 4381458 The Authors Reply http://www.medworm.com/index.php?rid=4263152&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000001%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4263152 Thu, 16 Dec 2010 13:58:26 +0100 4263152 Is There a Role for Pharmacoeconomics in Developing Countries? http://www.medworm.com/index.php?rid=4263151&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000001%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4263151 Thu, 16 Dec 2010 13:58:26 +0100 4263151 Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia http://www.medworm.com/index.php?rid=4263150&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000001%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4263150 Thu, 16 Dec 2010 13:58:26 +0100 4263150 Calibrating Models in Economic Evaluation: A Comparison of Alternative Measures of Goodness of Fit, Parameter Search Strategies and Convergence Criteria http://www.medworm.com/index.php?rid=4263149&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000001%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4263149 Thu, 16 Dec 2010 13:58:26 +0100 4263149 Calibrating Models in Economic Evaluation: A Seven-Step Approach http://www.medworm.com/index.php?rid=4263148&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000001%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4263148 Thu, 16 Dec 2010 13:58:26 +0100 4263148 Effects of Reference Pricing in Pharmaceutical Markets: A Review http://www.medworm.com/index.php?rid=4263147&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000001%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4263147 Thu, 16 Dec 2010 13:58:26 +0100 4263147 Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis http://www.medworm.com/index.php?rid=4263146&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2011%2F00000029%2F00000001%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4263146 Thu, 16 Dec 2010 02:06:32 +0100 4263146 The Cost Utility of Autologous Chondrocytes Implantation Using ChondroCelect in Symptomatic Knee Cartilage Lesions in Belgium http://www.medworm.com/index.php?rid=4178092&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000012%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4178092 Thu, 18 Nov 2010 16:15:56 +0100 4178092 Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance http://www.medworm.com/index.php?rid=4178091&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000012%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4178091 Thu, 18 Nov 2010 16:15:56 +0100 4178091 A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States http://www.medworm.com/index.php?rid=4178090&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000012%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4178090 Thu, 18 Nov 2010 16:15:56 +0100 4178090 Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices http://www.medworm.com/index.php?rid=4178089&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000012%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4178089 Thu, 18 Nov 2010 16:15:56 +0100 4178089 The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions: A Critical Appraisal of Recent Methodological Developments http://www.medworm.com/index.php?rid=4178088&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000012%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4178088 Thu, 18 Nov 2010 16:15:56 +0100 4178088 The Economics of a Liberated NHS http://www.medworm.com/index.php?rid=4178087&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000012%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4178087 Thu, 18 Nov 2010 16:15:56 +0100 4178087 Is There a Role for Pharmacoeconomics in Developing Countries? http://www.medworm.com/index.php?rid=4178086&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000012%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4178086 Thu, 18 Nov 2010 16:15:56 +0100 4178086 Acknowledgement http://www.medworm.com/index.php?rid=4178085&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000012%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4178085 Thu, 18 Nov 2010 02:06:30 +0100 4178085 Cost Effectiveness of Imiquimod 5 Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses: A Decision Tree Model http://www.medworm.com/index.php?rid=4064029&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00009 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064029 Thu, 14 Oct 2010 07:02:17 +0100 4064029 Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy http://www.medworm.com/index.php?rid=4064028&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064028 Thu, 14 Oct 2010 07:02:17 +0100 4064028 Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV http://www.medworm.com/index.php?rid=4064027&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064027 Thu, 14 Oct 2010 07:02:17 +0100 4064027 Economic Implications of Sleep Disorders http://www.medworm.com/index.php?rid=4064026&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064026 Thu, 14 Oct 2010 07:02:17 +0100 4064026 Cost Effectiveness of Pharmacogenomics: A Critical and Systematic Review http://www.medworm.com/index.php?rid=4064025&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064025 Thu, 14 Oct 2010 07:02:17 +0100 4064025 Methods of Model Calibration: Observations from a Mathematical Model of Cervical Cancer http://www.medworm.com/index.php?rid=4064024&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064024 Thu, 14 Oct 2010 07:02:17 +0100 4064024 An Analysis of NICEs Restricted (or Optimized) Decisions http://www.medworm.com/index.php?rid=4064023&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064023 Thu, 14 Oct 2010 07:02:17 +0100 4064023 Evaluation of Benefit-Risk http://www.medworm.com/index.php?rid=4064022&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064022 Thu, 14 Oct 2010 07:02:17 +0100 4064022 New Prescription for the Spanish Drug Sector: Fighting against Public Deficit without Wasting Ammunition http://www.medworm.com/index.php?rid=4064021&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000011%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=4064021 Thu, 14 Oct 2010 02:08:31 +0100 4064021 Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials http://www.medworm.com/index.php?rid=3961501&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00020 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961501 Mon, 13 Sep 2010 08:53:33 +0100 3961501 No Head-to-Head Trial? Simulate the Missing Arms http://www.medworm.com/index.php?rid=3961500&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00019 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961500 Mon, 13 Sep 2010 08:53:33 +0100 3961500 Theres a Reason They Call Them Dummy Variables: A Note on the Use of Structural Equation Techniques in Comparative Effectiveness Research http://www.medworm.com/index.php?rid=3961499&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00018 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961499 Mon, 13 Sep 2010 08:53:33 +0100 3961499 Comparative Effectiveness Without Head-to-Head Trials: A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept http://www.medworm.com/index.php?rid=3961498&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00017 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961498 Mon, 13 Sep 2010 08:53:33 +0100 3961498 Managed Care Pharmacy Sees Potential of Comparative Effectiveness Research to Improve Patient Care and Lower Costs http://www.medworm.com/index.php?rid=3961497&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00016 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961497 Mon, 13 Sep 2010 08:53:33 +0100 3961497 Comparative Effectiveness, Personalized Medicine and Innovation: The Path Forward http://www.medworm.com/index.php?rid=3961496&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00015 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961496 Mon, 13 Sep 2010 08:53:33 +0100 3961496 Comparative Effectiveness Research: The View from a Pharmaceutical Company http://www.medworm.com/index.php?rid=3961495&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00014 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961495 Mon, 13 Sep 2010 08:53:33 +0100 3961495 Comparative Effectiveness Research and Personalized Medicine: Catalyzing or Colliding? http://www.medworm.com/index.php?rid=3961494&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00013 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961494 Mon, 13 Sep 2010 08:53:33 +0100 3961494 Comparative Effectiveness Research and the Psychology of Medical Practice: The Vicissitudes of Knowledge Implementation http://www.medworm.com/index.php?rid=3961493&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00012 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961493 Mon, 13 Sep 2010 08:53:33 +0100 3961493 Perspective and Desire in Comparative Effectiveness Research: The Relative Unimportance of Mere Preferences, the Central Importance of Context http://www.medworm.com/index.php?rid=3961492&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00011 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961492 Mon, 13 Sep 2010 08:53:33 +0100 3961492 Comparative Effectiveness Regulations and Pharmaceutical Innovation http://www.medworm.com/index.php?rid=3961491&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00010 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961491 Mon, 13 Sep 2010 08:53:33 +0100 3961491 Cost-Effectiveness Analysis in Markets with High Fixed Costs http://www.medworm.com/index.php?rid=3961490&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00009 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961490 Mon, 13 Sep 2010 08:53:33 +0100 3961490 Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research: Strangers, Bedfellows or Strange Bedfellows? http://www.medworm.com/index.php?rid=3961489&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00008 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961489 Mon, 13 Sep 2010 08:53:33 +0100 3961489 The Economics of Comparative Effectiveness Studies: Societal and Private Perspectives and their Implications for Prioritizing Public Investments in Comparative Effectiveness Research http://www.medworm.com/index.php?rid=3961488&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961488 Mon, 13 Sep 2010 08:53:33 +0100 3961488 Guiding Comparative Effectiveness Research A US Perspective: An interview between Howard Birnbaum (of Analysis Group, Inc., and Guest Co-Editor of this Special Issue) and Jean R. S.sky (Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality) http://www.medworm.com/index.php?rid=3961487&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961487 Mon, 13 Sep 2010 08:53:33 +0100 3961487 Value-Based Approaches to Healthcare Systems and Pharmacoeconomics Requirements in Asia: South Korea, Taiwan, Thailand and Japan http://www.medworm.com/index.php?rid=3961486&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961486 Mon, 13 Sep 2010 08:53:33 +0100 3961486 International Comparison of Comparative Effectiveness Research in Five Jurisdictions: Insights for the US http://www.medworm.com/index.php?rid=3961485&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961485 Mon, 13 Sep 2010 08:53:33 +0100 3961485 Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS: Past, Present and Future http://www.medworm.com/index.php?rid=3961484&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961484 Mon, 13 Sep 2010 08:53:33 +0100 3961484 Perspectives on Comparative Effectiveness Research: Views from Diverse Constituencies http://www.medworm.com/index.php?rid=3961483&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961483 Mon, 13 Sep 2010 08:53:33 +0100 3961483 Introducing Perspectives on Comparative Effectiveness Research http://www.medworm.com/index.php?rid=3961482&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000010%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3961482 Sun, 12 Sep 2010 02:11:47 +0100 3961482 The Authors Reply http://www.medworm.com/index.php?rid=3927527&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000009%2Fart00009 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3927527 Fri, 03 Sep 2010 08:39:11 +0100 3927527 Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement:: A Systematic Review http://www.medworm.com/index.php?rid=3927525&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000009%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3927525 Fri, 03 Sep 2010 08:39:11 +0100 3927525 An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus http://www.medworm.com/index.php?rid=3927524&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000009%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3927524 Fri, 03 Sep 2010 08:39:11 +0100 3927524 Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder http://www.medworm.com/index.php?rid=3927523&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000009%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3927523 Fri, 03 Sep 2010 08:39:11 +0100 3927523 A New Method for Examining the Cost Savings of Reducing COPD Exacerbations http://www.medworm.com/index.php?rid=3927522&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000009%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3927522 Fri, 03 Sep 2010 08:39:11 +0100 3927522 Frequency of Treatment-Effect Modification Affecting Indirect Comparisons: A Systematic Review http://www.medworm.com/index.php?rid=3927521&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000009%2Fart00003 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3927521 Fri, 03 Sep 2010 08:39:11 +0100 3927521 Using Conjoint Analysis and Choice Experiments to Estimate QALY Values: Issues to Consider http://www.medworm.com/index.php?rid=3927520&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000009%2Fart00002 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3927520 Fri, 03 Sep 2010 08:39:11 +0100 3927520 The Value of Value of Information: Best Informing Research Design and Prioritization Using Current Methods http://www.medworm.com/index.php?rid=3927519&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000009%2Fart00001 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3927519 Fri, 03 Sep 2010 02:06:37 +0100 3927519 Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome http://www.medworm.com/index.php?rid=3752976&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000008%2Fart00007 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3752976 Thu, 15 Jul 2010 08:11:15 +0100 3752976 Economic Burden of Epilepsy among the Privately Insured in the US http://www.medworm.com/index.php?rid=3752975&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000008%2Fart00006 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3752975 Thu, 15 Jul 2010 08:11:15 +0100 3752975 Assessing the Relationship between Computational Speed and Precision: A Case Study Comparing an Interpreted versus Compiled Programming Language using a Stochastic Simulation Model in Diabetes Care http://www.medworm.com/index.php?rid=3752974&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000008%2Fart00005 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3752974 Thu, 15 Jul 2010 08:11:15 +0100 3752974 Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review http://www.medworm.com/index.php?rid=3752973&cid=s_33940_51_f&fid=33940&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpec%2F2010%2F00000028%2F00000008%2Fart00004 (Source: PharmacoEconomics) PharmacoEconomics journals http://www.medworm.com/rss/comments.php?id=3752973 Thu, 15 Jul 2010 08:11:15 +0100 3752973